Detalhe da pesquisa
1.
Cardiovascular Disease Risk Factor Control in People With and Without HIV.
Clin Infect Dis
; 78(5): 1264-1271, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38227614
2.
Characterizing Unhealthy Alcohol Use Patterns and Their Association with Alcohol Use Reduction and Alcohol Use Disorder During Follow-Up in HIV Care.
AIDS Behav
; 27(5): 1380-1391, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169779
3.
Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic.
BMC Health Serv Res
; 23(1): 494, 2023 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37194051
4.
Improved Gonorrhea and Chlamydia Testing Among Men Who Have Sex With Men Living With HIV Through Implementation of Self-Collected Tests.
Sex Transm Dis
; 48(11): e165-e167, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34110752
5.
Health System-Based Unhealthy Alcohol Use Screening and Treatment Comparing Demographically Matched Participants With and Without HIV.
Alcohol Clin Exp Res
; 44(12): 2545-2554, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067802
6.
Factors associated with suicidal ideation among people with HIV engaged in care.
J Affect Disord
; 358: 369-376, 2024 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723683
7.
Substance use and mental health factors associated with self-reported higher risk cannabis use among people with HIV screened in primary care.
Res Sq
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38853848
8.
Racial, ethnic, and age disparities in the association of mental health symptoms and polysubstance use among persons in HIV care.
PLoS One
; 18(11): e0294483, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015975
9.
The gut mucosal viral reservoir in HIV-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapy.
J Virol
; 85(10): 4772-82, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21345945
10.
Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016.
AIDS
; 36(3): 437-445, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34816805
11.
Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation-effectiveness study.
J Int AIDS Soc
; 25(9): e26006, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36097674
12.
Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE).
J Int AIDS Soc
; 25(9): e26003, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094142
13.
Effect of baseline characteristics on the efficacy and safety of once-daily darunavir/ ritonavir in HIV-1-infected, treatment-naïve ARTEMIS patients at week 96.
HIV Clin Trials
; 12(6): 313-22, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22189150
14.
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials.
Lancet HIV
; 7(6): e389-e400, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32504574
15.
Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration.
J Virol
; 82(1): 538-45, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17959677
16.
Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial.
Contemp Clin Trials
; 84: 105833, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446142
17.
Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI.
HIV Clin Trials
; 18(4): 141-148, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28689453
18.
Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Arch Surg
; 141(12): 1238-45, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17178967
19.
Social support and maladaptive coping as predictors of the change in physical health symptoms among persons living with HIV/AIDS.
AIDS Patient Care STDS
; 19(9): 587-98, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16164385
20.
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study.
J Acquir Immune Defic Syndr
; 69(4): 439-45, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25867913